Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
35.95
-1.06 (-2.88%)
Sep 14, 2026, 3:22 PM EDT - Market open

Nanobiotix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,8461,108148346135289
Market Cap Growth
297.86%646.34%-57.08%156.46%-53.41%-50.20%
Enterprise Value
1,8951,134131382116231
Last Close Price
37.0123.122.877.283.678.10

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
48.2328.95-19.938.6426.4296.13
PB Ratio
--11.17-2.18-169.73-4.669.50
P/TBV Ratio
-----9.50

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
49.5329.63-9.5322.6676.63

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.13-1.13-0.77-27.44-1.971.72
Net Debt / Equity Ratio
-0.50-0.50-0.0213.41-0.44-1.41
Net Debt / EBITDA Ratio
-4.06-4.06-0.021.09-0.270.83
Net Debt / FCF Ratio
-1.25-1.25-0.061.93-0.321.26
Asset Turnover
0.480.48-0.470.060.02
Quick Ratio
1.051.050.991.681.232.38
Current Ratio
1.091.091.041.751.382.53
Return on Equity (ROE)
------96.66%
Return on Assets (ROA)
-10.06%-10.06%-52.89%-19.72%-35.38%-25.00%
Return on Capital Employed (ROCE)
-106.10%-106.10%-804.70%-55.10%-209.40%-72.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.52%-2.54%-47.53%-12.69%-45.21%-18.47%
FCF Yield
-2.12%-3.60%-14.23%-4.09%-29.48%-11.83%
Buyback Yield / Dilution
-1.17%-1.17%-27.99%-5.96%-0.34%-42.43%
SEC Filings: 10-K · 10-Q